Navoximod, CAS [[1402837-78-8]]

Produktübersicht

• Artikelname: Navoximod, CAS [[1402837-78-8]]
• Artikelnummer: BYT-ORB1296225
• Hersteller Artikelnummer: orb1296225
• Alternativnummer: BYT-ORB1296225-1, BYT-ORB1296225-1, BYT-ORB1296225-10, BYT-ORB1296225-100, BYT-ORB1296225-25, BYT-ORB1296225-5, BYT-ORB1296225-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Indoleamine 2,3-Dioxygenase, Indoleamine 2,3Dioxygenase (IDO), Indoleamine 2,3-Dioxygenase (IDO), Indoleamine2,3Dioxygenase, inhibit, Indoleamine2,3Dioxygenase(IDO), Navoximod, NLG 919, NLG-919, NLG-?919, NLG919, NLG-919, Inhibitor, GDC 0919, GDC0919, GDC-0919, IDO

Produktbeschreibung

Navoximod (GDC-0919) is a potent small molecule inhibitor of the indoleamine 2,3-dioxygenase (IDO) pathway, exhibiting a Ki of 7 nM and an EC50 of 75 nM. It has been utilized in both in vitro and in vivo research to investigate immunomodulation, particularly in the fields of oncology and autoimmune disease.

Produkteigenschaften

• Molekulargewicht: 316.37
• Reinheit: 99.81% (May vary between batches)
• CAS Nummer: [1402837-78-8]
• Formel: C18H21FN2O2
• Target-Kategorie: IDO,Indoleamine 2,3-Dioxygenase (IDO)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (12.64 mM),DMSO:100 mg/mL (316.09 mM)